ACIU AC Immune
- 3.510
- -0.070-1.96%
- 3.480
- -0.030-0.85%
AC Immune News
DLocal, Allogene Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 20 points on Wednesday.Shares of DLocal Limited (NASDAQ:DLO) fell sharply in today's pre-market trading after
Buy Rating Affirmed: AC Immune's Promising Alzheimer's Vaccine and Strategic Takeda Partnership
The 38% Return This Week Takes AC Immune's (NASDAQ:ACIU) Shareholders One-year Gains to 57%
Passive investing in index funds can generate returns that roughly match the overall market. But you can significantly boost your returns by picking above-average stocks. For example, the AC Immune
The component stock Novavax Pharmaceuticals closed up 47.64%, continuing its 98.66% increase on Friday (May 10); AC Immune rose 42.86%, MacroGenics rose 32.33% Humacyte, Prime Medicine, Beam, Twist Bioscience, Recursion Pharmaceuticals, Coherus BioScience
The component stock Novavax Pharmaceuticals closed up 47.64%, continuing its 98.66% increase on Friday (May 10); AC Immune rose 42.86%, MacroGenics rose 32.33% Humacyte, Prime Medicine, Beam, Twist Bioscience, Recursion Pharmaceuticals, Coherus BioSciences rose 16.60%-10.00% Novocure also rose 9.17%; Zent
AC Immune ACIU Takeda Agreement; Novavax NVAX Sanofi Deal
Sector Update: Health Care
Health care stocks were mixed late Monday afternoon with the NYSE Health Care Index up 0.1% and the Health Care Select Sector SPDR Fund (XLV) decreasing 0.2%. The iShares Biotechnology ETF (IBB) added
Top Midday Gainers
CareCloud (CCLD) on Monday released details of an "unsolicited, non-binding indication of interest" on March 4 to acquire the company for $5 per share. The offer included a $25 redemption price per sh
FFIE, OGEN and CCLD Among Mid-day Movers
Crude Oil Surges Over 1%; Amprius Technologies Shares Plunge
U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining around 0.3% on Monday.The Dow traded down 0.01% to 39,509.81 while the NASDAQ rose 0.26% to 16,382.89. The S&
Alzheimer's vaccine concept stocks rose more than 30% to finalize more than $2 billion agreement with pharmaceutical giants
① Similar to previous infusion therapy, the AC Immune vaccine is designed to produce antibodies against beta-amyloid; ② However, compared to infusion treatment, the vaccine can greatly reduce the number of treatments required; ③ According to the progress of ACI-24.060, there are still several years to go until regulatory approval.
Takeda Shells Out $100m to License AC Immune's Phase II Alzheimer's Therapy
AC Immune (ACIU.US): The 2024 Q1 financial report achieved revenue of $0, previous value of $0, expected value of $6.05 million; earnings per share was -0.21 dollars, previous value was -0.23 dollars, and expected value was -0.15 dollars.
AC Immune (ACIU.US): The 2024 Q1 financial report achieved revenue of $0, previous value of $0, expected value of $6.05 million; earnings per share was -0.21 dollars, previous value was -0.23 dollars, and expected value was -0.15 dollars.
AC Immune Rockets 47% on Alzheimer's Therapy Deal With Takeda
Wall Street Set to Open Higher Monday as Investors Look Toward Key Inflation Figures
US stocks look set to open modestly higher in Monday's trading session as investors await key inflation data coming out during the week. Dow Jones Industrial Average futures were up 0.3%, S&P 500 futu
Takeda Pharmaceuticals (TAK.US) introduces AC Immune Alzheimer's Abeta vaccine therapy
On May 13, Takeda Pharmaceuticals (TAK.US) announced the introduction of AC Immune's Alzheimer's Abeta vaccine therapy ACI-24.060.
Market-Moving News for May 13th
GME: 46% | GameStop shares are trading higher amid possible retail investor interest following a social media post by Roaring Kitty.ACIU: 85% | AC Immune shares are trading higher after the company re
Strategic Boost: AC Immune's (ACIU) Share Price Surges Pre-Market
In response to recent strategic maneuvers, the shares of AC Immune SA (NASDAQ: ACIU) have experienced a notable surge in the pre-market session. At present, ACIU stock reflects an impressive uptick of 53.25% on the US charts, trading at $3.54. Revolutionary Collaboration Announced Today, AC Immune (ACIU) and Takeda established an exclusive global option and ...
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Ahead of Key Inflation Reports
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.2% and the actively traded Invesco QQQ Trust (QQQ) was 0.3% higher in Monday's premarket activity, ahead of key inflation re
Tevogen TVGN $50 Million in Financing; TAK AC Immune ACIU Option & License Agreement
Investors Eye Key Inflation Data in Days Ahead as US Futures Trend Modestly Higher Monday
US stock futures are trending modestly higher in Monday's premarket activity as investors await key inflation data coming out Tuesday and Wednesday, The Dow Jones Industrial Average futures were up 0.
Analysis
Price Target
No Data
